vTv Therapeutics (VTVT) Payables (2016 - 2025)
vTv Therapeutics (VTVT) has disclosed Payables for 12 consecutive years, with $6.6 million as the latest value for Q4 2025.
- Quarterly Payables rose 30.44% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 30.44% year-over-year, with the annual reading at $6.6 million for FY2025, 30.44% up from the prior year.
- Payables hit $6.6 million in Q4 2025 for vTv Therapeutics, down from $10.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $12.5 million in Q1 2022 to a low of $4.2 million in Q1 2025.
- Historically, Payables has averaged $7.6 million across 5 years, with a median of $7.4 million in 2022.
- Biggest five-year swings in Payables: plummeted 57.93% in 2021 and later surged 151.24% in 2022.
- Year by year, Payables stood at $8.3 million in 2021, then dropped by 8.96% to $7.5 million in 2022, then soared by 38.42% to $10.4 million in 2023, then plummeted by 51.82% to $5.0 million in 2024, then soared by 30.44% to $6.6 million in 2025.
- Business Quant data shows Payables for VTVT at $6.6 million in Q4 2025, $10.1 million in Q3 2025, and $5.2 million in Q2 2025.